Oncology & Cancer

Researchers discover BRCA1 gene is key for blood forming stem cells

Researchers at from the Harold C. Simmons Comprehensive Cancer Center have found that the BRCA1 gene is required for the survival of blood forming stem cells, which could explain why patients with BRCA1 mutations do not have ...

Oncology & Cancer

New colorectal cancer targeted therapy combination shows promise

New SWOG study results show significantly better outcomes for patients with a treatment-resistant form of metastatic colorectal cancer when the BRAF inhibitor vemurafenib is added to a standard treatment. The findings, for ...

Oncology & Cancer

Advanced lung cancer knocked out in clinical trial

A leading-edge immunotherapy clinical trial at UConn Health's Carole and Ray Neag Comprehensive Cancer Center has packed a one-two punch, successfully controlling a patient's advanced lung cancer using the combined power ...

Oncology & Cancer

Could a computer someday guide breast cancer care?

(HealthDay)β€”An artificially intelligent computer system is making breast cancer treatment recommendations on a par with those of cancer doctors, a new study reports.

Oncology & Cancer

Experts present triple-negative breast cancer immunotherapy trial

A researcher from University Hospitals Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at the 2016 San Antonio Breast Cancer Symposium. The annual symposium is ...

page 20 from 40